Sodium Hyaluronate Market

Market Overview

The global sodium hyaluronate market size was valued at USD 11.31 billion in 2022. It is estimated to reach USD 21.50 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2023–2031). The demand for such items is projected to act as a high-impact rendering driver for sodium hyaluronate products throughout the forecast period.

Sodium Hyaluronate refers to the naturally occurring substance extensively used in the medical and aesthetic fields. The body contains the glycosaminoglycan hyaluronic acid, also known as sodium hyaluronate. It is an excellent constituent for skin care products and other therapeutic applications due to its ability to retain moisture. Sodium hyaluronate is found in moisturizers, serums, creams, and other hygiene products. It hydrates the skin, reduces the appearance of wrinkles, and improves the skin's overall texture. It is renowned for retaining 1,000 times its weight in water, making it appear plumper and younger. Sodium hyaluronate is utilized in numerous medical procedures, including joint injections, eye surgery, and wound recovery. As a lubricant and shock absorber, it can alleviate patients suffering from dry eyes, arthritis, and osteoarthritis.

In recent years, the prevalence of chronic diseases requiring medical treatment and the demand for skincare and anti-aging products have increased dramatically, fuelling the sodium hyaluronate market significantly. The market includes producers, suppliers, distributors, and final consumers from the cosmetics and healthcare industries. The sodium hyaluronate market is anticipated to expand due to technological development, rising consumer interest in hygiene and wellness, and an aging population. In addition, the market is observing R&D initiatives to enhance the performance and quality of sodium hyaluronate-based products.

Market Dynamics

Global Sodium Hyaluronate Market Drivers

Growing Demand for Minimally Invasive Cosmetic Procedures

A growing worldwide aging population is mostly to blame for the rise in demand for antiaging cosmetics and aesthetic procedures that assist people in reversing their aging indications. In addition to having smaller molecules and higher skin penetration, sodium hyaluronate is more soluble than hyaluronic acid. Dermal fillers are injections into the skin to smooth out wrinkles and help restore a more youthful appearance, and they are used more frequently.

 Furthermore, sodium hyaluronate dermal fillers are preferred over procedures like Botox since they produce more natural results, making the patient feel more at ease and natural. Dermal filler injections are also minimally invasive and require little recovery time. Restylane Defyne, Refyne, and Restylane are some of the sodium hyaluronate dermal fillers on the market that have received FDA approval. So, the demand for such items is projected to act as a high-impact rendering driver for sodium hyaluronate products throughout the forecast period.

Increasing Prevalence of Non-Healing Wounds

It is projected that during the next few years, there will be an increase in the employment of topical sodium hyaluronate products for treating wounds that do not heal, such as skin ulcers and diabetic foot ulcers. The rising body of research results demonstrates that a significantly shorter period is required for patients to recover compared to standard care procedures. In addition, it is projected that the prevalence of diabetic foot ulcers will increase throughout the projection period as a direct result of the rising prevalence of diabetes worldwide. This is one of the reasons why the increase in the length of the projection period has been incorporated into the analysis.

Global Sodium Hyaluronate Market Restraint

Associated Adverse Effects of Sodium Hyaluronate

When sodium hyaluronate is used, it can lead to several unpleasant side effects, such as swelling of the eyelids, soreness in the face, pain, redness, and itching or swelling at the injection site. Sodium hyaluronate can also cause a burning sensation in the face. In addition, patients may report suffering additional symptoms such as stomach pain, difficulty swallowing due to treatment, shortness of breath, diarrhea, neck or back pain, muscle stiffness, fever and flu-like symptoms, anxiety, and so on.

Patients may also report experiencing other symptoms not listed here. The effects of dermal fillers are not permanent and may fade off anywhere from six months to eighteen months later, which may result in the requirement of further surgical procedures. The excruciating pain that comes with multiple injection cycles, each of which can be repeated, is another significant barrier to use.

Global Sodium Hyaluronate Market Opportunities

Increasing Prevalence of Chronic Disorders

The discomfort problem in the joints has become more widespread due to the growing population of older adults worldwide, particularly in China and Japan. The fact that joint disorders can be treated with hyaluronic acid has increased demand for the material. Hyaluronic acid can be exploited in the treatment of joint conditions. Additionally, there is a sizeable and well-established market for hyaluronic acid, particularly in the Asia-Pacific area. This market is predicted to grow to continue in the coming years. Additionally, an increase in the price of healthcare amenities may allow the market for hyaluronic acid to develop into a lucrative business.

Regional Analysis

Based on region, the global sodium hyaluronate market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Asia Pacific Dominates the Global Market

Asia-Pacific is the most significant global sodium hyaluronate market shareholder and is estimated to exhibit a CAGR of 8.2% over the forecast period. The Asia Pacific region is projected to experience significant expansion in the market for sodium hyaluronate in the coming years. In addition to India, countries such as China, Japan, and South Korea are the key contributors to the market's rise in this region. The demand for sodium hyaluronate in this region is driven by several causes, including an increase in individuals' discretionary expenditure, a higher understanding of skincare, and an increase in the number of individuals seeking medical tourism.

Additionally, the existence of a substantial population base and the development of an increasingly modern healthcare infrastructure are contributing factors to the expansion of the industry. Compared to surgical esthetics, the market for nonsurgical procedures is anticipated to expand more quickly throughout the projection period. This is primarily because there is a shorter recovery period and a perceived reduced risk of treatment. Additionally, China's expanding disposable income is anticipated to accelerate the uptake of cosmetic operations.

North America is anticipated to exhibit a CAGR of 7.6% over the forecast period. The high prevalence of diseases such as arthritis in North America and the rapidly aging population, which is increasingly seeking antiaging cosmetic procedures to reduce the signs of aging, are among the major factors responsible for the growth of the market for sodium hyaluronate-based products in the region. Sodium hyaluronate is also one of the main ingredients in many anti-aging cosmetic procedures. According to the American Academy of Facial Aesthetics, minimally invasive sodium hyaluronate-based dermal fillers, such as Restylane injections, are widely accepted in the region. This is primarily because these dermal fillers have a short average treatment time, which is in the range of 15 to 30 minutes, which enables patients to quickly return to work and their normal routine following the treatment.

In addition, patients have reported feeling more at ease with dermal fillers because of their transient nature, in contrast to permanent fillers, which can become a significant challenge and duty. The number of people who have arthritis in the North American region is on the rise, which has led to an increase in the demand for therapies that are based on sodium hyaluronate to treat the condition. Throughout the forecast period, these factors are anticipated to fuel growth in the sodium hyaluronate market in North America.

Europe holds a significant market share. According to a survey released by the International Society of Aesthetic Plastic Surgery, Europe has one of the highest rates of nonsurgical cosmetic treatments performed, led by nations like Italy, Germany, and France. Injections containing sodium hyaluronates, such as Restylane, STYLAGE, and Happy Cross from LABRHA SAS, among others, and botulinum toxin are also commonly utilized in the area. Hyacyst, a bladder installation based on NaHA, is widely available throughout the EU for treating increasingly common bladder disorders, including interstitial cystitis. A more youthful appearance is widely sought after by the region's rapidly aging population through aesthetic operations that can reverse outward signs of aging. More controls are anticipated to be implemented in the UK over the forecast period due to increased complaints about botched surgery.

Moreover, countries like Spain already have strict legislation that forbids anyone other than professional doctors from doing these procedures. The region's nations also provide strong healthcare systems, allowing people to receive almost free care for chronic diseases. Additionally, several rheumatology groups in the area frequently advise using injectables made of sodium hyaluronate to treat osteoarthritis. Additionally, due to the increasing aging population and increasing prevalence of osteoarthritis, there will be a surge in the need for injectables made of sodium hyaluronate to treat the ailment.

Latin America is a booming market. Countries like Brazil, Mexico, and Argentina are home to some of the most significant markets in this part of the world. The market's growth is partly fueled by external forces such as the increasing demand for cosmetic procedures, the rising levels of consumer expenditure on personal care products, and advancements in medical technology. In addition, the increasing prevalence of joint disorders, as well as the growing application of sodium hyaluronate as a treatment for osteoarthritis, are also aspects that are contributing to the rise of the market in Latin America.

The Middle East and Africa region is experiencing a rise in the demand for sodium hyaluronate, primarily driven by the rising level of awareness regarding skincare and cosmetic operations. The most important markets in this region are found in nations such as the United Arab Emirates, Saudi Arabia, and South Africa. The market's growth is supported by rising discretionary income levels, increasing medical tourism, and improving levels of healthcare infrastructure. Furthermore, a broad population base and the growing frequency of chronic diseases are contributing factors that make sodium hyaluronate a product in high demand.

Segmental Analysis

The global sodium hyaluronate market is bifurcated into type and application.

The global market is bifurcated into by type topical, injectables, and others based on the type. 

The injectables segment dominates the global market and is projected to exhibit a CAGR of 7.5% over the forecast period. In parenteral preparations, including but not limited to ocular viscosurgical devices (OVDs), intra-articular injections, and intradermal injections for aesthetic correction, sodium hyaluronate is widespread. It is regularly used in the treatment of knee pain brought on by osteoarthritis, and it is typically given in situations when other medications used in the treatment of knee pain brought on by osteoarthritis have not been beneficial. In addition, it is utilized in intrauterine therapies to lower adhesion to the surrounding tissues and quickly replenish the GAG layer in bladder conditions. This is done to accomplish both of these objectives. This is done to stop any adhesions from occurring.

In addition, the International Agency for the Prevention of Blindness projects that the number of ocular conditions that are frequently associated with age, such as cataracts, age-related macular degeneration, and glaucoma, will significantly increase over the next few years, primarily as a result of an aging population. These conditions include age-related cataracts, age-related macular degeneration, and glaucoma. Cataracts, glaucoma, and age-related macular degeneration are just a few eye disorders that can develop with age.

The global market is bifurcated into pharmaceutical and cosmetic based on application. 

The pharmaceutical segment owns the highest sodium hyaluronate market share and is predicted to exhibit a CAGR of 7.6% over the forecast period. An anionic, non-sulfated glycosaminoglycan, sodium hyaluronate can be found in large amounts throughout the body's connective, epithelial, and neural tissues. Sodium hyaluronate is very widely dispersed. Because it is highly viscous and possesses exceptional lubricating capabilities, it is essential for the upkeep of the vital activities of many different sections of the body, including the synovial joint, the heart valves, the skin, and the aqueous and vitreous humor of the eye.

As a result, it is used in a wide range of pharmaceutical applications, including as an injectable treatment for arthritis, as eye drops, and as an ophthalmic medical device that can be used for cataract surgery. Because of the rapidly increasing elderly population in many of the most important pharmaceutical markets worldwide in the coming years, the prevalence of certain diseases, particularly those related to the eye and joints, is expected to increase. As a result, the use of therapeutics that are based on sodium hyaluronate is also expected to increase proportionally.

Recent Developments

• April 2022- Bobbi Brown and Jones Road launched the "WTF" foundation formulated with jojoba oil, vitamin E, and sodium hyaluronate (a humectant that attracts moisture when applied to the skin).
• February 2022- Kukje Pharma launched a joint pain reliever, Kukje Hyal injection. The treatment comes in a pre-filled syringe, administered to the intra-knee joint or shoulder joint for five consecutive weeks.